A funding mechanism for antimicrobial resistance (AMR) becomes a priority as Tanzania’s government and members of Parliament champion sustainable financing for AMR interventions. The agreement emerged during a preliminary session held on the sidelines of the African Stakeholders’ Summit in Dar es Salaam, chaired by the government’s Chief Pharmacist, Daudi Masasi.
Participants identified key financial gaps hindering AMR programmes, including funding for research, laboratory testing, public education, antibiotic stewardship, and surveillance of resistant infections. Masasi underscored that lasting progress against AMR hinges on a solid financial framework capable of supporting timely and effective interventions.
As a result of the discussions, the side event committed to organizing a national parliamentary dialogue. This forum will convene MPs, health experts, private-sector representatives, and development partners to explore viable and sustainable financing strategies for AMR initiatives.
Leaders stressed that investing in the fight against AMR is crucial for protecting public health, curbing medical costs, strengthening domestic pharmaceutical capacity, and safeguarding the health-sector gains already achieved. The gathering marks a new phase in collaboration between the government and Parliament to intensify the battle against drug resistance.
During the event, alliance secretary Christina Mzava praised the MPs’ apparent resolve to elevate the AMR agenda within national policy and budget deliberations, signaling a renewed commitment to prioritize AMR in governance.
